Are foxO transcription factors implicated in osteoarthritis? influence of Diacerheind

Bio-Medical Materials and Engineering

Volumn 20, Issue 3-4, 2010, Pages 227-233

  De Isla, N ^a,b   Charif, N ^a,b   Stoltz, J F ^a,b,c  

^a CNRS   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

apoptosis; cartilage; Diacerhein; FoxO; osteoarthritis

Indexed keywords

APOPTOSIS; CELL DEDIFFERENTIATION; CHONDROCYTE PROLIFERATION; CHONDROCYTES; DEGRADING ENZYMES; DELETERIOUS EFFECTS; DIACERHEIN; DOWNSTREAM TARGET; ENERGY METABOLISM; FORKHEAD TRANSCRIPTION FACTORS; FOXO; GROWTH FACTOR; MODE OF ACTION; OSTEOARTHRITIS; TUMOR SUPPRESSION;

BODY FLUIDS; CELL DEATH; ENZYME INHIBITION; LIGAMENTS; METABOLISM; TRANSCRIPTION; TRANSCRIPTION FACTORS;

CARTILAGE;

ANTHRAQUINONE DERIVATIVE; DIACEREIN; FORKHEAD TRANSCRIPTION FACTOR;

ANIMAL; ARTICLE; ARTICULAR CARTILAGE; BIOLOGICAL MODEL; DRUG EFFECT; HUMAN; METABOLISM; OSTEOARTHRITIS;

ANIMALS; ANTHRAQUINONES; CARTILAGE, ARTICULAR; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MODELS, BIOLOGICAL; OSTEOARTHRITIS;

EID: 78649503188     PISSN: 09592989     EISSN: None     Source Type: Journal    
DOI: 10.3233/BME-2010-0636     Document Type: Conference Paper

References (12)

1. D.A. Salih and A. Brunet, FoxO transcription factors in the maintenance of cellular homeostasis during aging, Curr. Opin. Cell. Biol. 20 (2008), 126-136.
2. D.R. Calnan and A. Brunet, The FoxO code, Oncogene 27 (2008), 2276-2288.
3. A.S. Anderson and R.F. Loeser, Why is osteoarthritis an age-related disease?, Best Pract. Res. Clin. Rheumatol. 24 (2010), 15-26.
4. M.M. Temple-Wong, W.C. Bae, M.Q. Chen, W.D. Bugbee, D. Amiel, R.D. Coutts, M. Lotz and R.L. Sah, Biomechanical, structural, and biochemical indices of degenerative and osteoarthritic deterioration of adult human articular cartilage of the femoral condyle, Osteoarthritis Cartilage 17 (2009), 1469-1476.
5. K.A. Reedquist, J. Ludikhuize and P.P. Tak, Phosphoinositide 3-kinase signalling and FoxO transcription factors in rheumatoid arthritis, Biochem. Soc. Trans. 34 (2006), 727-730.
6. J. Ludikhuize, D. de Launay, D. Groot, T.J. Smeets, M. Vinkenoog, M.E. Sanders, S.W. Tas, P.P. Tak and K.A. Reedquist, Inhibition of forkhead box class O family member transcription factors in rheumatoid synovial tissue, Arthritis Rheum. 56 (2007), 2180-2191.
7. R.A. Kayal, M. Siqueira, J. Alblowi, J. McLean, N. Krothapalli, D. Faibish, T.A. Einhorn, L.C. Gerstenfeld and D.T. Graves, TNF-alpha mediates diabetes enhanced chondrocyte apoptosis during fracture healing and stimulates chon-drocyte apoptosis through FoxO-1, J. Bone Miner. Res. 25 (2010), 1604-1615.
8. J. Haag, Advances in the understanding of the role of aging in the development and progression of OA, Osteoarthritis Cartilage 17(Suppl. 1) (2009), S2.
9. N.G. de Isla, J.W. Yang, C. Huselstein, S. Muller and J.F. Stoltz, IL-1beta synthesis by chondrocyte analyzed by 3D microscopy and flow cytometry: effect of Rhein, Biorheology 43 (2006), 595-601.
10. N.G. de Isla, D. Mainard, S. Muller and J.F. Stoltz, In vitro effects of diacerein on NO production by chondrocytes in response to proinflammatory mediators, Biomed. Mater. Eng. 18 (2008), S99-S104.
11. F. Legendre, A. Heuze, K. Boukerrouche, S. Leclercq, K. Boumediene, P. Galera, F. Domagala, J.P. Pujol and H. Ficheux, Rhein, the metabolite of diacerhein, reduces the proliferation of osteoarthritic chondrocytes and synoviocytes without inducing apoptosis, Scand. J. Rheumatol. 38 (2009), 104-111.
12. J.F. Stoltz, N. de Isla, C. Huselstein, D. Bensoussan, S. Muller and V. Decot, Mechanobiology and cartilage engineering: the underlying pathophysiological phenomena, Biorheology 43 (2006), 171-180.